CTDH

 
Class A Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 9/06/2017
Contact Info
  • 6714 NW 16th Street
  • Suite B
  • Gainesville, FL 32563

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000922247
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2860 - Industrial Organic Chemicals
Incorporated In: FL, USA
Year of Inc. 1992
Employees 6 a/o Mar 17, 2017
Company Officers/Contacts
N. Scott Fine CEO
Jeffrey L. Tate COO, Chief Scientific Officer
Kevin J Strattan VP, Fin.
Company Directors
N. Scott Fine Chairman
Joseph J. Farnan Independent Director
F. Patrick Ostronic Independent Director, Audit Committee Member
Markus W. Sieger Independent Director, Compensation Committee Member
Jeffrey L. Tate
Service Providers
Accounting/Auditing Firm
WithumSmith+Brown
180 S. Orange #1150
Suite 1150
Orlando, FL, 32801
United States
 
Securities Counsel
Fox Rothschild LLP
3800 Howard Hughes Pky.
Suite 500
Las vegas, NV, 89169
United States
 
Investor Relations Firm
Sitrick Brincko Group, LLC
1801 W. Olympic Blvd
Pasadena, CA, 91109-1102
United States
 
Company History
  • Formerly=Cyclodextrin Technologies Development, Inc. until 5-00
CTDH Security Details
Share Structure
Market Value1 $22,545,839 a/o Dec 14, 2017
Authorized Shares 100,000,000 a/o Dec 01, 2017
Outstanding Shares 73,105,834 a/o Dec 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 16,005,303 a/o Apr 11, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 112 a/o Mar 17, 2017
Short Selling Data
Short Interest 1,861 (100%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security